In 2018, Wataru Sakamoto and his research team found that neutral ceramidase (nCDase), which regulates sphingolipid metabolism, is located in the Golgi apparatus of colon cancer cells and protects cells from ceramide-induced apoptosis9. The gene discussed is ASAH2; the disease is colonic neoplasm.